BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15899101)

  • 1. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients.
    Elsammak M; Refai W; Elsawaf A; Abdel-Fattah I; Abd Elatti E; Ghazal A
    Curr Med Res Opin; 2005 Apr; 21(4):527-34. PubMed ID: 15899101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
    Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia.
    Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Palomo Gil S; Grilo Reina A
    Rev Esp Enferm Dig; 2001 Oct; 93(10):639-48. PubMed ID: 11767488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.
    Knobler H; Schattner A
    QJM; 2005 Jan; 98(1):1-6. PubMed ID: 15625348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
    Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
    Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between hepatitis C, diabetes mellitus, and race. a case-control study.
    Thuluvath PJ; John PR
    Am J Gastroenterol; 2003 Feb; 98(2):438-41. PubMed ID: 12591065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the impact of hepatitis C virus on insulin resistance and arterial stiffness in hemodialysis patients.
    Adam FU; Torun D; Yigit F; Ozelsancak R; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2008; 30(4):411-5. PubMed ID: 18569915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and lichen planus in patients with HCV-infectious liver diseases.
    Nagao Y; Kawasaki K; Sata M
    J Gastroenterol Hepatol; 2008 Apr; 23(4):580-5. PubMed ID: 18397487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
    Yoneda M; Saito S; Ikeda T; Fujita K; Mawatari H; Kirikoshi H; Inamori M; Nozaki Y; Akiyama T; Takahashi H; Abe Y; Kubota K; Iwasaki T; Terauchi Y; Togo S; Nakajima A
    J Viral Hepat; 2007 Sep; 14(9):600-7. PubMed ID: 17697011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
    Valenti L; Pulixi E; Fracanzani AL; Dongiovanni P; Maggioni M; Orsatti A; Gianni C; Fargion S
    J Hepatol; 2005 Dec; 43(6):944-50. PubMed ID: 16143422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.
    Visnegarwala F; Chen L; Raghavan S; Tedaldi E
    J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
    Kawaguchi T; Ide T; Taniguchi E; Hirano E; Itou M; Sumie S; Nagao Y; Yanagimoto C; Hanada S; Koga H; Sata M
    Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
    Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
    Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
    J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y; Mizuta T; Oza N; Takahashi H; Ario K; Yoshimura T; Eguchi Y; Ozaki I; Hisatomi A; Fujimoto K
    Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.